Hubei Goto Biopharm Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	75.48	85.85	141.18	181.97	438.42	209.91
Trading Asset Securities	0	0	0	0	15.01	0.1
Cash & Short-Term Investments	75.48	85.85	141.18	181.97	453.43	210.02
Cash Growth	-51.97%	-39.19%	-22.42%	-59.87%	115.90%	625.10%
Accounts Receivable	228.1	189.1	214.26	235.4	269.36	243.86
Other Receivables	4.26	3.3	2.05	2.15	1.88	2.09
Receivables	232.36	192.4	216.31	237.54	271.25	245.95
Inventory	486.54	473.76	384.8	396.16	432.5	371.24
Prepaid Expenses	-	-	-	-	-	1.68
Other Current Assets	30.79	18.28	27.7	54.06	56.56	29.37
Total Current Assets	825.17	770.29	770	869.73	1,214	858.26
Property, Plant & Equipment	1,868	1,883	1,849	1,391	610.94	256.57
Long-Term Investments	47.06	48.29	48.27	48.24	48.08	14.47
Other Intangible Assets	53.48	53.79	49.88	51	43.14	27.82
Long-Term Deferred Tax Assets	65.6	62.77	37.29	22.62	17.89	8.82
Long-Term Deferred Charges	5.73	6.56	9.69	13.3	13.96	0.97
Other Long-Term Assets	30.78	26.12	25.78	51.96	121.56	44.34
Total Assets	2,896	2,851	2,790	2,448	2,069	1,211
Accounts Payable	491.59	461.26	459.91	532.24	205.52	138.17
Accrued Expenses	5.65	9.64	12.43	9.25	9.58	7.51
Short-Term Debt	220.76	229.75	294.3	110.09	321.63	143.41
Current Portion of Long-Term Debt	98.38	95.35	24.55	22.27	5.24	-
Current Portion of Leases	-	-	0.06	0.45	1.98	11.47
Current Income Taxes Payable	0.97	0.43	0.08	2.8	7.21	11.27
Current Unearned Revenue	4.3	6.59	1.23	3.47	2.01	3.7
Other Current Liabilities	11.56	19.06	15.13	5.84	22.79	17.65
Total Current Liabilities	833.21	822.08	807.69	686.41	575.97	333.18
Long-Term Debt	998.79	974.16	812.64	652.37	437.04	-
Long-Term Leases	-	-	-	0.54	4.41	6.67
Long-Term Unearned Revenue	152.38	144.06	150.25	84.33	69.71	42.98
Long-Term Deferred Tax Liabilities	1.1	0.98	0.01	0.29	0.97	0
Other Long-Term Liabilities	0.02	0.02	4.65	0.03	0.05	-
Total Liabilities	1,986	1,941	1,775	1,424	1,088	382.83
Common Stock	115.28	115.28	115.28	115.28	115.28	115.28
Additional Paid-In Capital	409.15	409.02	410.6	410.77	409.11	409.11
Retained Earnings	230.61	227.41	300.77	330.2	307.2	282.67
Treasury Stock	-21.97	-21.97	-	-	-	-
Comprehensive Income & Other	96.48	96.48	96.49	96.49	96.51	-
Total Common Equity	829.55	826.22	923.14	952.75	928.09	807.05
Minority Interest	81.06	83.14	91.5	71.03	53.07	21.36
Shareholders' Equity	910.61	909.36	1,015	1,024	981.16	828.42
Total Liabilities & Equity	2,896	2,851	2,790	2,448	2,069	1,211
Total Debt	1,318	1,299	1,132	785.73	770.3	161.54
Net Cash (Debt)	-1,242	-1,213	-990.37	-603.75	-316.87	48.47
Net Cash Per Share	-10.88	-10.59	-8.61	-5.25	-2.76	0.46
Filing Date Shares Outstanding	106.62	110.98	115.28	115.28	115.28	115.28
Total Common Shares Outstanding	106.62	110.98	115.28	115.28	115.28	115.28
Working Capital	-8.04	-51.79	-37.69	183.33	637.76	525.08
Book Value Per Share	7.78	7.44	8.01	8.26	8.05	7.00
Tangible Book Value	776.06	772.43	873.26	901.75	884.95	779.23
Tangible Book Value Per Share	7.28	6.96	7.58	7.82	7.68	6.76
Buildings	-	-	506.33	129.73	108.67	95.53
Machinery	-	-	820.79	207.89	196.16	180.78
Construction In Progress	324.11	-	694.41	1,182	411.99	66.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.